Sermion tablets 5 mg for brain metabolism
Product Code :
Availability : Out Of Stock
General information on Japanese tablets Sermion tablets 5 mg for brain metabolism
Package details: 100 tablets
Manufacturer: Mitsubishi Tanabe Pharma, Japan
Active ingredient: nicergoline 5 mg (chemical formula C24H26BrN3O3)
Medical effect: Sermion tablets increase cerebral blood flow, inhibit platelet aggregation and improve cerebral circulation and metabolism. They are used for the treatment of following diseases and conditions:
- senile dementia,
- avolition caused by chronic cerebrovascular disorder,
- acute and chronic cerebral and peripheral metabolic-vascular disorders,
- migraines of vascular origin,
- diabetic retinopathy,
- macular degeneration,
- retinal angiosclerosis.
Contraindications and precautions:
Do not use in patients in case their haemostasis of intracranial haemorrhage has not been established. Do not use in children, pregnant or breastfeeding women. Patients with acute bleeding, myocardial infarction, hypertension, bradycardia or using alpha or beta receptor agonists should consult with their doctor before use.
It should not be used for drivers of vehicles and people whose profession is associated with increased concentration of attention. During treatment, it is necessary to refrain from drinking alcohol.
Dosage and administration of Japanese Sermion tablets 5 mg for brain metabolism
Take 1 tablet 2 times a day, after breakfast and dinner. The consulting doctor may adjust the dose due to age and symptoms.
About the effectiveness of Sermion tablets 5 mg for brain metabolism from Japan
Japanese tablets Sermion contain in each tablet 5 mg of nicergoline, ergot fungi derivative used for decreasing vascular resistance and increasing arterial blood flow in the brain. Nicergoline improves the utilization of oxygen and glucose by brain cells, improves cerebral circulation and metabolism. Sermion tablets are used for treatment of senile dementia (including Alzheimer's disease and vascular dementia).
Studies show that nicergoline is effective in up to 89% of patients with dementia of different aetiologies, significantly improving cognition and behavior (B. Winblad, M. Fiorovanti et al. Therapeutic use of nicergoline. Clinical drug investigation, 2008, 28(9): 533-52). Moreover, Sermion tablets are effective for treatment of vascular and balance disorders, including cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.